Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,086	842	438	383	394	257
Market Cap Growth	92.35%	92.35%	14.25%	-2.77%	53.22%	-42.71%
Enterprise Value	692	471	146	147	240	184
Last Close Price	1.10	1.03	0.47	0.38	0.36	0.22
PE Ratio	9.01	6.99	4.37	4.14	4.82	4.12
PS Ratio	2.76	2.14	1.33	1.21	1.39	1.17
PB Ratio	1.87	1.45	0.88	0.82	0.98	0.82
P/TBV Ratio	2.14	1.66	1.03	1.00	1.25	1.11
P/FCF Ratio	8.39	6.51	4.48	3.15	4.54	2.51
P/OCF Ratio	7.55	5.85	4.19	2.98	3.92	2.37
EV/Sales Ratio	1.96	1.20	0.44	0.46	0.85	0.84
EV/EBITDA Ratio	5.59	3.45	1.27	1.38	2.38	2.37
EV/EBIT Ratio	5.96	3.65	1.38	1.51	2.63	2.67
EV/FCF Ratio	5.35	3.64	1.49	1.21	2.77	1.79
Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.21	0.22
Debt / EBITDA Ratio	0.26	0.26	0.57	0.58	0.83	0.88
Debt / FCF Ratio	0.27	0.27	0.67	0.51	0.97	0.67
Asset Turnover	0.52	0.52	0.50	0.51	0.49	0.46
Inventory Turnover	2.07	2.07	1.99	2.12	2.13	1.97
Quick Ratio	3.09	3.09	2.60	2.47	2.06	1.80
Current Ratio	3.32	3.32	2.86	2.68	2.25	2.00
Return on Equity (ROE)	22.07%	22.07%	21.38%	21.53%	21.64%	19.98%
Return on Assets (ROA)	10.73%	10.73%	9.93%	9.66%	9.93%	8.98%
Return on Capital (ROIC)	13.41%	13.41%	12.39%	12.05%	12.53%	11.60%
Return on Capital Employed (ROCE)	21.80%	21.80%	20.60%	20.20%	22.00%	21.00%
Earnings Yield	11.10%	14.31%	22.87%	24.18%	20.73%	24.28%
FCF Yield	11.92%	15.37%	22.34%	31.73%	22.03%	39.84%
Dividend Yield	9.65%	7.24%	11.20%	9.59%	9.39%	13.59%
Payout Ratio	74.75%	74.75%	41.59%	18.67%	33.56%	26.36%
Buyback Yield / Dilution	-4.12%	-4.12%	-0.91%	1.58%	1.54%	4.35%
Total Shareholder Return	5.53%	3.12%	10.29%	11.17%	10.92%	17.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.